BILASTINE
Clinical Indication
Allergic rhinoconjunctivitis and urticaria
Date of classification
November 2023
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.